Oxford university and AstraZeneca are to resume the international clinical trial of their proposed coronavirus vaccine c...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...
Intravacc, a global leader in translational research and development of viral and bacterial vaccines in the Netherlands,...
A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successf...
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, as a potential candidate for an emergency use authorization (EU...
Korea's LSK Global PS, a leading CRO to run Sinovac Phase III COVID-19 vaccine trial in Bangladesh. The company would m...
Beximco Pharmaceuticals Limited (BPL) in Bangladesh and the Serum Institute of India Pvt. Ltd (SII), have announced an a...
On 25 August 2020, Indian Health Ministery announced that a dialogue has been exchanged between India and Russia on...
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced it has signed two agreeme...
For the first time ever, Taiwan's Food and Drug Administration (FDA) has given conditional approval for the experimental...
Australia has inked an agreement with British pharmaceutical giant AstraZeneca to supply Australians with the ...
Japan's FUJIFILM Diosynth Biotechnologies, world-leading contract development and manufacturing organization (CDMO) for ...
China's CanSino Biologics Inc. announced on 13 August 2020 that it has successfully listed on the Sci-Tech Innovati...
Australia is progressing with its new and improved Q Fever vaccine at pre-clinical trials following a $1.87 million inje...
The world’s first Phase III trials of an inactivated vaccine for COVID-19 being held in the United Arab Emirates h...
AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...
Johnson & Johnson on 5 August 2020 announced it's Janssen Pharmaceutical Companies have entered into an agreeme...
Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from ...
